Literature DB >> 9482705

Allergen-specific nasal challenge: response kinetics of clinical and inflammatory events to rechallenge.

G Ciprandi1, V Ricca, M Landi, G Passalacqua, M Bagnasco, G W Canonica.   

Abstract

Allergen-specific nasal challenge is a valid and reliable tool for studying the pathophysiological mechanisms involved in allergic inflammation. Nasal challenge induces an immediate clinical response in allergic subjects and a concomitant appearance of an inflammatory infiltrate. The mucosal inflammation may persist up to 48-72 h after allergen exposure. If the subjects are rechallenged within this period the response is more pronounced: the so-defined priming effect. The aim of the study was to evaluate the effects of the nasal rechallenge, performed at different time intervals: 3 days, 1, 2 and 4 weeks after the first challenge. Forty allergic subjects underwent two nasal challenges: at baseline and after the periods mentioned above (10/group). Symptoms and inflammatory cells (eosinophils and neutrophils recovered by nasal brushing) were assessed. The 3-day-interval group showed a hyperreactive response (priming effect), the 1- and 4-week-interval groups showed a response similar to baseline, and the 2-week-interval group showed a hyporeactive response ('tolerogenic effect'). The last phenomenon may be due to a possible immunologic response similar to that achievable during local specific immunotherapy. The present results further elucidate the kinetics of allergen-driven inflammatory events and highlight the importance of the time period chosen for rechallenge. The latter fact may be of primary importance in clinical trials involving specific challenge.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9482705     DOI: 10.1159/000023896

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  6 in total

1.  Mitochondrial dysfunction increases allergic airway inflammation.

Authors:  Leopoldo Aguilera-Aguirre; Attila Bacsi; Alfredo Saavedra-Molina; Alexander Kurosky; Sanjiv Sur; Istvan Boldogh
Journal:  J Immunol       Date:  2009-09-28       Impact factor: 5.422

2.  Local nasal specific immunotherapy for allergic rhinitis.

Authors:  Giovanni Passalacqua; Giorgio Walter Canonica
Journal:  Allergy Asthma Clin Immunol       Date:  2006-09-15       Impact factor: 3.406

3.  The Allergic Rhinitis - Clinical Investigator Collaborative (AR-CIC): nasal allergen challenge protocol optimization for studying AR pathophysiology and evaluating novel therapies.

Authors:  Anne K Ellis; Mena Soliman; Lisa Steacy; Marie-Ève Boulay; Louis-Philippe Boulet; Paul K Keith; Harissios Vliagoftis; Susan Waserman; Helen Neighbour
Journal:  Allergy Asthma Clin Immunol       Date:  2015-04-24       Impact factor: 3.406

4.  The Allergic Rhinitis Clinical Investigator Collaborative (AR-CIC): verification of nasal allergen challenge procedures in a study utilizing an investigational immunotherapy for cat allergy.

Authors:  Helen Neighbour; Mena Soliman; Lisa M Steacy; Pascal Hickey; Beth Forbes; Mark Larché; Anne K Ellis
Journal:  Clin Transl Allergy       Date:  2018-04-12       Impact factor: 5.871

Review 5.  Review: The Nose as a Route for Therapy. Part 2 Immunotherapy.

Authors:  Yorissa Padayachee; Sabine Flicker; Sophia Linton; John Cafferkey; Onn Min Kon; Sebastian L Johnston; Anne K Ellis; Martin Desrosiers; Paul Turner; Rudolf Valenta; Glenis Kathleen Scadding
Journal:  Front Allergy       Date:  2021-07-01

Review 6.  EAACI position paper on occupational rhinitis.

Authors:  Gianna Moscato; Olivier Vandenplas; Roy Gerth Van Wijk; Jean-Luc Malo; Luca Perfetti; Santiago Quirce; Jolanta Walusiak; Roberto Castano; Gianni Pala; Denyse Gautrin; Hans De Groot; Ilenia Folletti; Mona Rita Yacoub; Andrea Siracusa
Journal:  Respir Res       Date:  2009-03-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.